Search research articles
Contact Us
Filters
Showing results (11-20 of 58) with videos related to
Page
of 6
Sort By:
Annals of Translational Medicine
|
September 15, 2015
Advances in the diagnosis, treatment and prognosis of malignant pleural mesothelioma
Weiquan Zhang, Xinshu Wu, Licun Wu, et al.
Scientific Reports
|
January 20, 2022
A panel of emerging EMT genes identified in malignant mesothelioma
Licun Wu, Shaheer Amjad, Hana Yun, et al.
The Lancet. Oncology
|
September 9, 2017
Radiotherapy for the treatment of malignant pleural mesothelioma
Marc de Perrot, Licun Wu, Matthew Wu, et al.
Scientific Reports
|
March 14, 2025
Mesothelioma cell heterogeneity identified by single cell RNA sequencing
Licun Wu, Zongjie Wang, Amin Zia, et al.
Molecular Cancer Therapeutics
|
May 16, 2012
CTLA-4 blockade expands infiltrating T cells and inhibits cancer cell repopulation during the intervals of chemotherapy in murine mesothelioma
Licun Wu, Zhihong Yun, Tetsuzo Tagawa, et al.
Journal of Clinical Medicine
|
November 13, 2021
IRF3 Knockout Results in Partial or Complete Rejection of Murine Mesothelioma
Masaya Aoki, Licun Wu, Junichi Murakami, et al.
Oncology Reports
|
March 14, 2013
Impact of acetylsalicylic acid on tumor angiogenesis and lymphangiogenesis through inhibition of VEGF signaling in a murine sarcoma model
Xiaoyue Zhang, Zhaopeng Wang, Zhaoxia Wang, et al.
Stem Cell Reports
|
March 14, 2017
Stem Cell Factor-Based Identification and Functional Properties of In Vitro-Selected Subpopulations of Malignant Mesothelioma Cells
Walter Blum, László Pecze, Emanuela Felley-Bosco, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 7, 2011
Tumor cell repopulation between cycles of chemotherapy is inhibited by regulatory T-cell depletion in a murine mesothelioma model
Licun Wu, Zhihong Yun, Tetsuzo Tagawa, et al.
Oncology Reports
|
March 21, 2014
Antitumor effect of a selective COX-2 inhibitor, celecoxib, may be attributed to angiogenesis inhibition through modulating the PTEN/PI3K/Akt/HIF-1 pathway in an H₂₂ murine hepatocarcinoma model
Wenwen Sui, Yueying Zhang, Zhaopeng Wang, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 58) with videos related to
Sort By:
Page
of 6
Annals of Translational Medicine
|
September 15, 2015
Advances in the diagnosis, treatment and prognosis of malignant pleural mesothelioma
Weiquan Zhang, Xinshu Wu, Licun Wu, et al.
Scientific Reports
|
January 20, 2022
A panel of emerging EMT genes identified in malignant mesothelioma
Licun Wu, Shaheer Amjad, Hana Yun, et al.
The Lancet. Oncology
|
September 9, 2017
Radiotherapy for the treatment of malignant pleural mesothelioma
Marc de Perrot, Licun Wu, Matthew Wu, et al.
Scientific Reports
|
March 14, 2025
Mesothelioma cell heterogeneity identified by single cell RNA sequencing
Licun Wu, Zongjie Wang, Amin Zia, et al.
Molecular Cancer Therapeutics
|
May 16, 2012
CTLA-4 blockade expands infiltrating T cells and inhibits cancer cell repopulation during the intervals of chemotherapy in murine mesothelioma
Licun Wu, Zhihong Yun, Tetsuzo Tagawa, et al.
Journal of Clinical Medicine
|
November 13, 2021
IRF3 Knockout Results in Partial or Complete Rejection of Murine Mesothelioma
Masaya Aoki, Licun Wu, Junichi Murakami, et al.
Oncology Reports
|
March 14, 2013
Impact of acetylsalicylic acid on tumor angiogenesis and lymphangiogenesis through inhibition of VEGF signaling in a murine sarcoma model
Xiaoyue Zhang, Zhaopeng Wang, Zhaoxia Wang, et al.
Stem Cell Reports
|
March 14, 2017
Stem Cell Factor-Based Identification and Functional Properties of In Vitro-Selected Subpopulations of Malignant Mesothelioma Cells
Walter Blum, László Pecze, Emanuela Felley-Bosco, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 7, 2011
Tumor cell repopulation between cycles of chemotherapy is inhibited by regulatory T-cell depletion in a murine mesothelioma model
Licun Wu, Zhihong Yun, Tetsuzo Tagawa, et al.
Oncology Reports
|
March 21, 2014
Antitumor effect of a selective COX-2 inhibitor, celecoxib, may be attributed to angiogenesis inhibition through modulating the PTEN/PI3K/Akt/HIF-1 pathway in an H₂₂ murine hepatocarcinoma model
Wenwen Sui, Yueying Zhang, Zhaopeng Wang, et al.
Page
of 6